Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus

Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the Euro Heart Survey on Diabetes and the Heart

(2010) M. Anselmino et al.   EUROPEAN HEART JOURNAL

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

(2010) Michael Böhm et al.   LANCET

Competing Risk Regression Models for Epidemiologic Data

(2009) B. Lau et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

(2009) X. Du et al.   EUROPEAN HEART JOURNAL

Baseline Heart Rate, Antihypertensive Treatment, and Prevention of Cardiovascular Outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial)

(2009) Neil R. Poulter et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Heart Rate in Cardiovascular Diseases: A Target for Treatment?

(2009) Paolo Palatini   PROGRESS IN CARDIOVASCULAR DISEASES

J-SHAPED RELATIONSHIP BETWEEN RESTING PULSE RATE AND ALL-CAUSE MORTALITY IN COMMUNITY-DWELLING OLDER PEOPLE WITH DISABILITIES

(2008) Masafumi Kuzuya et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE